Developer docs
API playgroundTry for free, no card

Search company profiles

Ropca

Full company profile

uuid0009qdg

Namestring
Ropca
Websiteurl
ropca.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Ropca is a Denmark-based artificial intelligence company, founded in 2019 in Odense, that develops automated medical ultrasound devices intended for the diagnosis of arthritis. The company's value proposition centers on applying AI to automate ultrasound imaging interpretation, addressing the manual-expertise bottleneck in arthritis diagnosis where clinical decisions today depend on trained rheumatologists or radiologists performing and reading scans. The product is positioned as a medical device, implying it operates in a regulated environment requiring conformity assessment and clinical validation before commercial deployment.

The company is at an early stage: headcount is reported at 1-10 employees, no funding rounds, partnerships, certifications, patents, named customers, or product-level technical specifications are disclosed in the available source data. The company website currently renders only a verification/loading screen, limiting public visibility into product architecture, pricing, go-to-market, and distribution. Leadership is limited to a single disclosed executive, Johannes Schaeferhoff as Chief Executive Officer.

No revenue model, pricing structure, customer segments, or go-to-market channels are documented. Given the medical-device nature of the product, plausible commercialization paths would include direct sales to hospitals and rheumatology clinics, distribution through medical-imaging OEMs, or a software-as-a-medical-device (SaMD) licensing model — but none of these are confirmed in the source data. The investment picture is therefore nascent: a focused AI medical-device thesis in a real clinical need area, but with very limited disclosed evidence of execution milestones, capital raised, or commercial traction.

Short descriptiontext

Ropca is a Denmark-based AI company, founded in 2019, developing automated medical ultrasound devices intended for the diagnosis of arthritis. It serves the rheumatology and clinical diagnostics market with an AI-driven imaging interpretation product.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOdense, Denmark
HQ citystring
Odense
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
medical imaging AI, automated ultrasound devices, arthritis diagnosis, medical device software, AI healthcare diagnostics
Industry4 codes
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Devices
Social media profiles2 records
Cost components4 values
Technology or R&D, Supply Chain, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ropca develops automated medical ultrasound devices powered by artificial intelligence for the diagnosis of arthritis. The company combines purpose-built ultrasound hardware with AI-based image analysis to enable automated detection and assessment of arthritic conditions, targeting clinical and healthcare use cases.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Automated Medical Ultrasound Device for Arthritis Diagnosis
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Maker of a handheld, AI-enabled ultrasound probe and software platform used across multiple clinical indications including musculoskeletal. Directly comparable to Ropca on the convergence of portable ultrasound hardware and embedded AI for image interpretation.

TypeDirect peer
Description

Develops handheld, smartphone-connected ultrasound scanners with AI-assisted imaging presets, including musculoskeletal workflows. Closely comparable to Ropca as a portable, AI-assisted ultrasound vendor pursuing non-radiologist users.

TypeBroad incumbent
Description

One of the largest ultrasound OEMs globally, with a broad LOGIQ and Venue portfolio and an expanding AI musculoskeletal imaging roadmap. Represents the incumbent competitive backdrop against which a focused AI-ultrasound startup must differentiate.

TypeBroad incumbent
Description

Major imaging OEM with ultrasound systems and AI-driven quantification tools used in musculoskeletal and point-of-care settings. Comparable as an incumbent defining the standard of care Ropca's automation play must displace or complement.

TypeBroad incumbent
Description

Global ultrasound and imaging OEM with AI-enabled MSK and joint assessment features across its ACUSON portfolio. Relevant incumbent peer shaping clinical expectations for AI-assisted MSK imaging.

TypeBroad incumbent
Description

OEM of diagnostic ultrasound systems with AI musculoskeletal packages and growing presence in compact and point-of-care form factors. Comparable as an established player expanding into the same AI-ultrasound territory Ropca targets.

TypeEmerging player
Description

Cloud-native AI imaging analytics platform with FDA-cleared algorithms across multiple modalities. Comparable as a specialist in AI interpretation layers that could be deployed alongside or in competition with Ropca's ultrasound AI.

TypeEmerging player
Description

Specialist in AI-driven clinical imaging workflows with regulatory clearances for triage and notification. Comparable as a regulated, AI-first imaging software company whose commercialization playbook is informative for Ropca.

TypeBroad incumbent
Description

Diversified medical device manufacturer with a strong ultrasound portfolio increasingly incorporating AI features. Comparable as a global OEM competing on price-performance in musculoskeletal and point-of-care ultrasound.

TypeEmerging player
Description

European-headquartered ultrasound specialist with deep roots in musculoskeletal and rheumatology imaging. Closely comparable given overlapping clinical focus (MSK/rheumatology) and its European footprint adjacent to Ropca's Danish base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ropca

Medical Imaging Devicesropca.com

Ropca is a Denmark-based AI company, founded in 2019, developing automated medical ultrasound devices intended for the diagnosis of arthritis. It serves the rheumatology and clinical diagnostics market with an AI-driven imaging interpretation product.

What Ropca does

Ropca is a Denmark-based artificial intelligence company, founded in 2019 in Odense, that develops automated medical ultrasound devices intended for the diagnosis of arthritis. The company's value proposition centers on applying AI to automate ultrasound imaging interpretation, addressing the manual-expertise bottleneck in arthritis diagnosis where clinical decisions today depend on trained rheumatologists or radiologists performing and reading scans. The product is positioned as a medical device, implying it operates in a regulated environment requiring conformity assessment and clinical validation before commercial deployment.

The company is at an early stage: headcount is reported at 1-10 employees, no funding rounds, partnerships, certifications, patents, named customers, or product-level technical specifications are disclosed in the available source data. The company website currently renders only a verification/loading screen, limiting public visibility into product architecture, pricing, go-to-market, and distribution. Leadership is limited to a single disclosed executive, Johannes Schaeferhoff as Chief Executive Officer.

No revenue model, pricing structure, customer segments, or go-to-market channels are documented. Given the medical-device nature of the product, plausible commercialization paths would include direct sales to hospitals and rheumatology clinics, distribution through medical-imaging OEMs, or a software-as-a-medical-device (SaMD) licensing model — but none of these are confirmed in the source data. The investment picture is therefore nascent: a focused AI medical-device thesis in a real clinical need area, but with very limited disclosed evidence of execution milestones, capital raised, or commercial traction.

Ropca firmographics

Firmographics
Name
Ropca
Website
https://ropca.com
Company type
Private
Founded year
2019
Headcount range
11–50 employees
Short description
Ropca is a Denmark-based AI company, founded in 2019, developing automated medical ultrasound devices intended for the diagnosis of arthritis. It serves the rheumatology and clinical diagnostics market with an AI-driven imaging interpretation product.
Ownership category
akta.pro rank

Ropca industry classification

Industry
Product category
Medical Imaging Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Medical imaging AI
  • Automated ultrasound devices
  • Arthritis diagnosis
  • Medical device software
  • AI healthcare diagnostics

Where Ropca is headquartered

Location

Headquarters

HQ city
Odense
HQ country
Denmark
HQ region
Europe

Markets served

Ropca business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations

Ropca product offering

Product offering

Core offering

Ropca develops automated medical ultrasound devices powered by artificial intelligence for the diagnosis of arthritis. The company combines purpose-built ultrasound hardware with AI-based image analysis to enable automated detection and assessment of arthritic conditions, targeting clinical and healthcare use cases.

Differentiator

Problem solved

Functional benefit

Products and services

  • Automated Medical Ultrasound Device for Arthritis Diagnosis

Companies that use Ropca

Customer profile

Ideal customer profiles1 record

Ropca technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ropca partnerships and signals

Strategic signal

Recent moves2 records

Ropca competitors and assessment

Company assessment

Direct peers

  • Butterfly Network: Maker of a handheld, AI-enabled ultrasound probe and software platform used across multiple clinical indications including musculoskeletal. Directly comparable to Ropca on the convergence of portable ultrasound hardware and embedded AI for image interpretation.
  • Clarius Mobile Health: Develops handheld, smartphone-connected ultrasound scanners with AI-assisted imaging presets, including musculoskeletal workflows. Closely comparable to Ropca as a portable, AI-assisted ultrasound vendor pursuing non-radiologist users.

Broad incumbents

  • GE HealthCare: One of the largest ultrasound OEMs globally, with a broad LOGIQ and Venue portfolio and an expanding AI musculoskeletal imaging roadmap. Represents the incumbent competitive backdrop against which a focused AI-ultrasound startup must differentiate.
  • Philips: Major imaging OEM with ultrasound systems and AI-driven quantification tools used in musculoskeletal and point-of-care settings. Comparable as an incumbent defining the standard of care Ropca's automation play must displace or complement.
  • Siemens Healthineers: Global ultrasound and imaging OEM with AI-enabled MSK and joint assessment features across its ACUSON portfolio. Relevant incumbent peer shaping clinical expectations for AI-assisted MSK imaging.
  • Samsung Medison: OEM of diagnostic ultrasound systems with AI musculoskeletal packages and growing presence in compact and point-of-care form factors. Comparable as an established player expanding into the same AI-ultrasound territory Ropca targets.
  • Mindray: Diversified medical device manufacturer with a strong ultrasound portfolio increasingly incorporating AI features. Comparable as a global OEM competing on price-performance in musculoskeletal and point-of-care ultrasound.

Emerging players

  • Arterys: Cloud-native AI imaging analytics platform with FDA-cleared algorithms across multiple modalities. Comparable as a specialist in AI interpretation layers that could be deployed alongside or in competition with Ropca's ultrasound AI.
  • Viz.ai: Specialist in AI-driven clinical imaging workflows with regulatory clearances for triage and notification. Comparable as a regulated, AI-first imaging software company whose commercialization playbook is informative for Ropca.
  • Esaote: European-headquartered ultrasound specialist with deep roots in musculoskeletal and rheumatology imaging. Closely comparable given overlapping clinical focus (MSK/rheumatology) and its European footprint adjacent to Ropca's Danish base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Ropca social profiles

Digital presence

Ropca financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ropca leadership team

Management profile

Number of profiles

Profiles1 record

Ropca funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ropca M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ropca

What does Ropca do?

Ropca develops automated medical ultrasound devices powered by artificial intelligence for the diagnosis of arthritis. The company combines purpose-built ultrasound hardware with AI-based image analysis to enable automated detection and assessment of arthritic conditions, targeting clinical and healthcare use cases.

When was Ropca founded?

Ropca was founded in 2019. It employs 11 to 50 people.

Where is Ropca based?

Ropca is headquartered in Odense, Denmark, in the Europe region.

Who are Ropca's main competitors?

Direct peers on record are Butterfly Network and Clarius Mobile Health. Broad incumbents are GE HealthCare, Philips, Siemens Healthineers, Samsung Medison and Mindray. Emerging players are Arterys, Viz.ai and Esaote.

Does Ropca have an API?

No public API is recorded for Ropca.

What industry is Ropca in?

Ropca's product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales